Original Article

Effects of L-Carnitine on Glycemic Control and C-Peptide Levels in Patients with Type 2 Diabetes Mellitus

Volume 12 · Issue 1 Publish Date: June 1, 2008
Full Text PDF
Shahram Hadadinezhad
Department of Endocrinology and Metabolism Ekbatan Hospital Hamedan University of Medical Science Hamedan, Iran
Nargess Ghazaleh
Department of Endocrinology and Metabolism Ekbatan Hospital Hamedan University of Medical Science Hamedan, Iran
Zahra Razavi
Department of Endocrinology and Metabolism Ekbatan Hospital Hamedan University of Medical Science Hamedan, Iran
Hadadinezhad, S., Ghazaleh, N., & Razavi, Z. (2008). Effects of L-Carnitine on Glycemic Control and C-Peptide Levels in Patients with Type 2 Diabetes Mellitus. Endocrinology Research and Practice, 12(1), 1–3. Retrieved from https://endocrinolrespract.org/index.php/pub/article/view/458
Full Text Full Text PDF

Abstract

Abstract
Objective: This study investigates the effects of L-carnitine on glycemic control in non–insulin-dependent patients with diabetes mellitus.
Materials and Methods: The effects of L-carnitine on levels of blood glucose and C-peptides were studied in 25 women and 35 men with type 2 diabetes mellitus, with an average age of 53.3 years. Patients were randomized to either the L-carnitine or the placebo group. Duringa 3-month period, 1 g oral L-carnitine or placebo was administrated 3 times a day (3 g/day).
Results: A significant reduction was observed in the fasting blood glucose level in the L-carnitine group at Week 12 (end of study) compared with the level at baseline: 143.93 ± 34.74 mg/dL and 129.43 ± 32.16 mg/dL, respectively (p < 0.05). No significant changes were observed in either group for concentrations of 2-hour postprandial blood glucose, hemoglobin A1C, or C-peptides.
Conclusions: L-carnitine significantly reduced the fasting blood glucose level at Week 12 but had no effect on 2-hour postprandial blood glucose levels, hemoglobin A1C concentrations, or C-peptide levels in patients with non–insulin-dependent diabetes mellitus.

Tip 2 Diyabetik Hastalarda L-Karnitinin Glisemik Kontrol ve C-Peptid Üzerine Olan Etkileri

Özet
Amaç: Bu çalışma, insüline bağımlı olmayan diabetik hastalarda, L- kartinin’in glisemik kontrol üzerine etkilerini araştırmak üzere gerçekleşmiştir.
Gereç ve Yöntem: Yaş ortalaması 53.3 olan tip 2 diyabetik 35 erkek ve 25 kadında L-karnitinin kan şekeri ve C-peptid düzeyleri üzerine etkileri araştırıldı. Hastalar rastgele olarak L-karnitin ve plasebo olmak üzere 2 gruba ayrıldı. Her iki gruba ağ›zdan günde 3kez 1 gram 3 ay süreyle uygulandı.
Bulgular: L-karnitin grubunda açlık kan şekeri 3 ay içinde anlamlı düşme (143.93±34.74mg/dl’den 129.43±32.16mg/dl’ye) gösterdi. Her iki grupta 2. saat postprandial kan şekeri değeri, hemoglobin A1c ve C-peptid değeri bakımından anlamlı değişiklik gözlenmedi.
Sonuç: L-karnitin 3 ay içinde açlık kan şekeri değerlerini düşürmekle birlikte 2. saat postprandial, hemoglobin A1c ve C-peptid değerleri üzerine etkili değildir.
Anahtar kelimeler: L- kartinin, tip 2 diyabet, c-peptid

Article Info
Published In
Journal Endocrinology Research and Practice
Volume / Issue Volume 12 · Issue 1
Pages 1-3
History
Published Online June 1, 2008
Copyright
Affiliations
Shahram Hadadinezhad
Department of Endocrinology and Metabolism Ekbatan Hospital Hamedan University of Medical Science Hamedan, Iran
Nargess Ghazaleh
Department of Endocrinology and Metabolism Ekbatan Hospital Hamedan University of Medical Science Hamedan, Iran
Zahra Razavi
Department of Endocrinology and Metabolism Ekbatan Hospital Hamedan University of Medical Science Hamedan, Iran
Cite this Article
Hadadinezhad, S., Ghazaleh, N., & Razavi, Z. (2008). Effects of L-Carnitine on Glycemic Control and C-Peptide Levels in Patients with Type 2 Diabetes Mellitus. Endocrinology Research and Practice, 12(1), 1–3. Retrieved from https://endocrinolrespract.org/index.php/pub/article/view/458
Outlines